13 MAR 2025 · Jared Baeten is senior vice president in virology at Gilead Sciences. Jared's problem is this: In a world without a vaccine, how do you make a medicine that people will actually take to help prevent HIV?
There’s already a daily pill that reduces the risk of getting HIV, but a majority of people who are at high risk are unwilling or unable to take it.
So Jared and his colleagues are developing a new drug, lenacapivir, designed to be given as a shot once every six months. Note: The views and opinions expressed in this episode are those of the guest and do not necessarily reflect the views or positions of any entities they represent. Get early, ad-free access to episodes of What's Your Problem? by subscribing to Pushkin+ on Apple Podcasts or http://pushkin.fm/. Pushkin+ subscribers can access ad-free episodes, full audiobooks, exclusive binges, and bonus content for all Pushkin shows.
Subscribe on Apple: http://apple.co/pushkin
Subscribe on Pushkin: https://www.pushkin.fm/join-pushkinSee https://omnystudio.com/listener for privacy information.